Maintenance Service for BD Biosciences Flow Cytometers
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Centers for Disease Control and Prevention (CDC) Office of Acquisition Services intends to award a sole source firm-fixed-price order to Becton, Dickinson and Company for a service maintenance agreement for BD Biosciences Flow Cytometers at the CDC's Immunology and Pathogenesis Branch (NCIRD) in Atlanta, GA. This notice is an intent to award, not a request for competitive quotations. Responses from interested parties are due by January 29, 2026.
Scope of Work
The requirement is for a Premium Service Plan for three specific BD Biosciences flow cytometers (FACSympohony A5, FACSLyric 2, FACSDiscover S8 BRVTGUV). These instruments are critical for ongoing clinical studies. The service plan must include:
- OEM-certified preventative maintenance (at least twice annually)
- Unscheduled corrective maintenance
- Access to proprietary diagnostic tools
- Installation of OEM-issued software, firmware, and security updates
- Use of genuine OEM replacement parts
- Manufacturer-authorized technical and application support
- Maximum 24-hour response time for technical support
- Maximum 48-hour response time for on-site repair services
Contract & Timeline
- Type: Sole Source, Firm-Fixed-Price Order
- Awardee (Intended): Becton, Dickinson and Company (BD Biosciences is a part of BD)
- Set-Aside: None specified (sole source)
- Period of Performance:
- Base Period: February 1, 2026 – January 31, 2027
- Option Period 1: February 1, 2027 – January 31, 2028
- Response Due: January 29, 2026, by 2:00 p.m. ET
- Published: January 27, 2026
Sole Source Justification
Becton, Dickinson and Company is the Original Equipment Manufacturer (OEM) of the identified flow cytometers. As the OEM, they maintain exclusive ownership and control of proprietary software, firmware, diagnostic utilities, calibration tools, engineering documentation, and specialized replacement parts. They are the only source available to provide fully guaranteed technical support, parts, and maintenance services for these systems.
Action for Interested Parties
Interested parties may identify their interest and submit documentation of their capability to perform the maintenance service requirement. While this is not a request for competitive quotations, responses will be considered to determine if a competitive procurement is feasible. Submissions should be emailed to the Contracting Officer, Serina Allingham, at xog9@cdc.gov.